International Respiratory and Severe Illness Center, University of Washington, Seattle, WA, USA.
Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of Washington, Seattle, WA, USA.
Crit Care. 2018 Sep 23;22(1):232. doi: 10.1186/s13054-018-2157-z.
Sepsis is a major contributor to the global burden of disease. The majority of sepsis cases and deaths are estimated to occur in low and middle-income countries. Barriers to reducing the global burden of sepsis include difficulty quantifying attributable morbidity and mortality, low awareness, poverty and health inequity, and under-resourced and low-resilience public health and acute health care delivery systems. Important differences in the populations at risk, infecting pathogens, and clinical capacity to manage sepsis in high and low-resource settings necessitate context-specific approaches to this significant problem. We review these challenges and propose strategies to overcome them. These strategies include strengthening health systems, accurately identifying and quantifying sepsis cases, conducting inclusive research, establishing data-driven and context-specific management guidelines, promoting creative clinical interventions, and advocacy.
脓毒症是全球疾病负担的主要原因。据估计,大多数脓毒症病例和死亡发生在中低收入国家。降低脓毒症全球负担的障碍包括难以量化可归因于发病率和死亡率、意识水平低、贫困和健康不平等以及资源不足和弹性低的公共卫生和急性医疗保健提供系统。高资源和低资源环境中面临风险的人群、感染病原体以及管理脓毒症的临床能力存在重要差异,因此需要针对这一重大问题采取具体情况具体分析的方法。我们回顾了这些挑战并提出了克服这些挑战的策略。这些策略包括加强卫生系统、准确识别和量化脓毒症病例、开展包容性研究、制定基于数据和具体情况的管理指南、推广有创意的临床干预措施以及宣传倡导。
Crit Care. 2018-9-23
Intensive Care Med. 2017-3-27
J Infect. 2017-6
Lancet Child Adolesc Health. 2022-2
Lancet Infect Dis. 2009-9
Cardiol Young. 2017-12
Epilepsy Behav. 2020-4
J Health Soc Policy. 2004
Sci One Health. 2025-6-28
Front Public Health. 2025-7-1
World J Crit Care Med. 2025-6-9
Int J Mol Sci. 2025-5-18
AMIA Annu Symp Proc. 2025-5-22
Parasite Epidemiol Control. 2018-6-18
BMC Med. 2018-6-4
Clin Lab Med. 2018-3
BMC Infect Dis. 2017-9-11